cupure logo

Zepbound News

Novo Nordisk Sues Eli Lilly Over Alleged Misleading Advertising for Obesity Drugs

Novo Nordisk sues Eli Lilly over obesity drug ads

Zepbound is an obesity treatment medication marketed by Eli Lilly for weight management.